Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia - Aix-Marseille Université Access content directly
Journal Articles Nature Cancer Year : 2021

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

Tony Kaoma
No file

Dates and versions

Identifiers

Cite

Claudie Bosc, Estelle Saland, Aurélie Bousard, Noémie Gadaud, Marie Sabatier, et al.. Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia. Nature Cancer, 2021, 2 (11), pp.1204-1223. ⟨10.1038/s43018-021-00264-y⟩. ⟨hal-03565962⟩
35 View
3 Download

Altmetric

Share

Gmail Facebook X LinkedIn More